A股異動 | 富瀚微(300613.SZ)漲逾8% 擬收購眸芯科技32.43%股權
格隆匯2月8日丨富瀚微(300613.SZ)高開高走,現報152.93元,漲幅8.32%,最新總市值122.34億。公司上週五公吿稱,擬收購眸芯科技32.43%股權,代價3.3億元。完成後,公司持有的眸芯科技股權比例將由18.57%變更為51%,眸芯科技將成為公司的控股子公司。標的公司主要產品為智能視頻監控系統後端設備(DVR、NVR等)主處理器SoC芯片及帶屏顯的智能家居類電子設備主處理器SoC芯片等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.